Return to Main Menu »

Course Overview

This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives
After attending this live internet activity, participants should be able to:

• Discuss the algorithm and steps to treatment and eradication of Hepatitis B and C.
• Describe the diagnosis and treatment of common liver disease such as PBC, PSC, and new updates in the treatment of NASH.
• Discuss what the non-transplant physician needs to know in the treatment of HCC with systemic therapies and post transplant complications.

View Conference Brochure »

View Faculty Disclosures »

How to Claim CME Credits »